Authors: Olopade, OI Pichert, G

Citation: Oi. Olopade et G. Pichert, Cancer genetics in oncology practice, ANN ONCOL, 12(7), 2001, pp. 895-908

Authors: Ghielmini, M Schmitz, SFH Burki, K Pichert, G Betticher, DC Stupp, R Wernli, M Lohri, A Schmitter, D Bertoni, F Cerny, T

Citation: M. Ghielmini et al., The effect of Rituximab on patients with follicular and mantle-cell lymphoma, ANN ONCOL, 11, 2000, pp. 123-126

Authors: Pichert, G Stahel, RA

Citation: G. Pichert et Ra. Stahel, Organizing cancer genetics programs: The Swiss model, J CL ONCOL, 18(21), 2000, pp. 65S-69S

Authors: Schmitter, D Bolliger, U Hallek, M Pichert, G

Citation: D. Schmitter et al., Involvement of the CD27-CD70 co-stimulatory pathway in allogeneic T-cell response to follicular lymphoma cells, BR J HAEM, 106(1), 1999, pp. 64-70

Authors: Stahel, RA Jost, LM Kroner, T Dommann-Scherrer, C Maurer, R Glanzmann, C Jacky, E Pichert, G Pestalozzi, B Marincek, B Sauter, C Honegger, H

Citation: Ra. Stahel et al., A prospective study of risk-adapted therapy for large cell non-Hodgkin's lymphoma with VACOP-B followed by high-dose CBV and autologous progenitor cell transplantation for high-risk patients in remission, BR J HAEM, 104(4), 1999, pp. 763-769